Pavlos Msaouel

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 75

Top Topics

Tyrosine Kinase

Top Venues

Nature communications

Clinical trials (London, England)

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander D Sherry, Pavlos Msaouel, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin, Cullen M Taniguchi, Clifton David Fuller, Bruce D Minsky, Ethan Bernard Ludmir
Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trials. The oncologist (2024)
Alexander D Sherry, Timothy A Lin, Zachary Ryan McCaw, Esther J Beck, Ramez Kouzy, Joseph Abi Jaoude, Adina H Passy, Avital M Miller, Gabrielle S Kupferman, Clifton David Fuller, Charles R Thomas, Eugene Jon Koay, Chad Tang, Pavlos Msaouel, Ethan Bernard Ludmir
Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trials. International journal of cancer (2024)
Chandra Sekhar Amara, Karthik Reddy Kami Reddy, Yang Yuntao, Yuen San Chan, Danthasinghe Waduge Badrajee Piyarathna, Lacey Elizabeth Dobrolecki, David J H Shih, Zhongcheng Shi, Jun Xu, Shixia Huang, Matthew J Ellis, Andrea B Apolo, Leomar Y Ballester, Jianjun Gao, Donna E Hansel, Yair Lotan, H Courtney Hodges, Seth P Lerner, Chad J Creighton, Arun Sreekumar, Wenjin Jim Zheng, Pavlos Msaouel, Shyam M Kavuri, Nagireddy Putluri
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer. Nature communications 15 (1) (2024)
Alexander D Sherry, Pavlos Msaouel, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin, Cullen M Taniguchi, Clifton David Fuller, Bruce D Minsky, Ethan Bernard Ludmir
Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trials. The oncologist 29 (7) (2024)
Matthew T Campbell, Amishi Yogesh Shah, Pavlos Msaouel, Nizar M Tannir, Arlene O Siefker-Radtke, Ashish M Kamat, Neema Navai, Colin P N Dinney, Priya Rao, Charles C Guo, Rahul A Sheth, Aradhana M Venkatesan, Rebecca S Slack Tidwell, Shalini Singh Yadav, Aidi Gu, Hong Chen, Marc Macaluso, Fei Duan, Sreyashi Basu, Sonali Jindal, Padmanee Sharma
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle Invasive Bladder Cancer. Cancer research communications (2024)
Bradley R Webster, Christopher J Ricketts, Cathy D Vocke, Dionna Gamble, Daniel R Crooks, Ye Yang, Lindsay Friedman, Antoun Toubaji, Pavlos Msaouel, Jonathan M Hernandez, W Marston Linehan, Mark W. Ball
Molecular Characterization of Metastatic Oncocytoma With Exceptional Response to Treatment: A Case Report. JCO precision oncology 8 (2024)
Eric J Hsu, Timothy A Lin, Dor R Dabush, Zachary McCaw, Alex Koong, Christine Lin, Joseph Abi Jaoude, Roshal Patel, Ramez Kouzy, Molly B El Alam, Sonal Noticewala, Yumeng Yang, Alexander D Sherry, Clifton D Fuller, Charles R Thomas, Chad Tang, Pavlos Msaouel, Prajnan Das, Bo Huang, Lu Tian, Ryan Sun, J Jack Lee, Tomer Meirson, Ethan Bernard Ludmir
Association of differential censoring with survival and suboptimal control arms among oncology clinical trials. Journal of the National Cancer Institute 116 (6) (2024)
Esther J Beck, Alexander D Sherry, Marcus A Florez, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin, Avital M Miller, Adina H Passy, Gabrielle S Kupferman, Roshal R Patel, Fumiko L Chino, Victoria Serpas Higbie, Christine M Parseghian, Michael James Overman, Bruce D Minsky, Charles R Thomas, Chad Tang, Pavlos Msaouel, Ethan Bernard Ludmir
Secondary endpoint utilization and publication rate among phase III oncology trials. Cancer research communications (2024)
Andrew W Hahn, Rebecca S Slack Tidwell, Patrick G Pilie, Yao Yu, Jingjing Liu, Devaki Shilpa Surasi, Mark Titus, Jianhua Zhang, Neha Venkatesh, Theocharis Panaretakis, Justin R Gregg, Amado J Zurita, Bilal A Siddiqui, Paul G Corn, Sumit K Subudhi, Pavlos Msaouel, Efstratios Koutroumpakis, Chad D Huff, Ana M Aparicio, Jennifer L McQuade, Daniel E Frigo, Christopher L Logothetis
Body composition as a determinant of the therapeutic index with androgen signaling inhibition. Prostate cancer and prostatic diseases (2024)
Andrew C Johns, Matthew T Campbell, Mamie Gao, Andrew W Hahn, Zita Lim, Emily Wang, Jianjun Gao, Amishi Y Shah, Pavlos Msaouel, Nizar M Tannir
Efficacy, Safety, and Tolerability of Tivozanib in Heavily Pretreated Patients With Advanced Clear Cell Renal Cell Carcinoma. The oncologist 29 (7) (2024)
Bradley R Webster, Christopher J Ricketts, Cathy D Vocke, Dionna Gamble, Daniel R Crooks, Ye Yang, Lindsay Friedman, Antoun Toubaji, Pavlos Msaouel, Jonathan M Hernandez, W Marston Linehan, Mark W. Ball
Molecular Characterization of Metastatic Oncocytoma With Exceptional Response to Treatment: A Case Report. JCO precision oncology 8 (2024)
Esther J Beck, Alexander D Sherry, Marcus A Florez, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin, Avital M Miller, Adina H Passy, Gabrielle S Kupferman, Roshal R Patel, Fumiko L Chino, Victoria Serpas Higbie, Christine M Parseghian, Michael James Overman, Bruce D Minsky, Charles R Thomas, Chad Tang, Pavlos Msaouel, Ethan Bernard Ludmir
Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials. Cancer research communications 4 (8) (2024)
Alexander D Sherry, Pavlos Msaouel, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin, Cullen M Taniguchi, Clifton David Fuller, Bruce D Minsky, Ethan Bernard Ludmir
Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trials. The oncologist 29 (7) (2024)
Chandra Sekhar Amara, Karthik Reddy Kami Reddy, Yang Yuntao, Yuen San Chan, Danthasinghe Waduge Badrajee Piyarathna, Lacey Elizabeth Dobrolecki, David J H Shih, Zhongcheng Shi, Jun Xu, Shixia Huang, Matthew J Ellis, Andrea B Apolo, Leomar Y Ballester, Jianjun Gao, Donna E Hansel, Yair Lotan, H Courtney Hodges, Seth P Lerner, Chad J Creighton, Arun Sreekumar, Wenjin Jim Zheng, Pavlos Msaouel, Shyam M Kavuri, Nagireddy Putluri
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer. Nature communications 15 (1) (2024)
Andrew C Johns, Matthew T Campbell, Mamie Gao, Andrew W Hahn, Zita Lim, Emily Wang, Jianjun Gao, Amishi Y Shah, Pavlos Msaouel, Nizar M Tannir
Efficacy, Safety, and Tolerability of Tivozanib in Heavily Pretreated Patients With Advanced Clear Cell Renal Cell Carcinoma. The oncologist 29 (7) (2024)
Bradley R Webster, Christopher J Ricketts, Cathy D Vocke, Dionna Gamble, Daniel R Crooks, Ye Yang, Lindsay Friedman, Antoun Toubaji, Pavlos Msaouel, Jonathan M Hernandez, W Marston Linehan, Mark W. Ball
Molecular Characterization of Metastatic Oncocytoma With Exceptional Response to Treatment: A Case Report. JCO precision oncology 8 (2024)
Andrew C Johns, Matthew T Campbell, Mamie Gao, Andrew W Hahn, Zita Lim, Emily Wang, Jianjun Gao, Amishi Y Shah, Pavlos Msaouel, Nizar M Tannir
Efficacy, Safety, and Tolerability of Tivozanib in Heavily Pretreated Patients With Advanced Clear Cell Renal Cell Carcinoma. The oncologist (2024)
Esther J Beck, Alexander D Sherry, Marcus A Florez, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin, Avital M Miller, Adina H Passy, Gabrielle S Kupferman, Roshal R Patel, Fumiko L Chino, Victoria Serpas Higbie, Christine M Parseghian, Michael James Overman, Bruce D Minsky, Charles R Thomas, Chad Tang, Pavlos Msaouel, Ethan Bernard Ludmir
Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials. Cancer research communications 4 (8) (2024)
Mohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, Sagar A Naik, Vivek Subbiah, Matthew T Campbell, Pavlos Msaouel, Parminder Singh, Omar Alhalabi
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy. Current oncology (Toronto, Ont.) 31 (6) (2024)
Esther J Beck, Alexander D Sherry, Marcus A Florez, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin, Avital M Miller, Adina H Passy, Gabrielle S Kupferman, Roshal R Patel, Fumiko L Chino, Victoria Serpas Higbie, Christine M Parseghian, Michael James Overman, Bruce D Minsky, Charles R Thomas, Chad Tang, Pavlos Msaouel, Ethan Bernard Ludmir
Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials. Cancer research communications 4 (8) (2024)
Mohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, Sagar A Naik, Vivek Subbiah, Matthew T Campbell, Pavlos Msaouel, Parminder Singh, Omar Alhalabi
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy. Current oncology (Toronto, Ont.) 31 (6) (2024)
Alexander D Sherry, Pavlos Msaouel, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin, Cullen M Taniguchi, Clifton David Fuller, Bruce D Minsky, Ethan Bernard Ludmir
Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trials. The oncologist 29 (7) (2024)
Mohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, Sagar A Naik, Vivek Subbiah, Matthew T Campbell, Pavlos Msaouel, Parminder Singh, Omar Alhalabi
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy. Current oncology (Toronto, Ont.) 31 (6) (2024)
Chandra Sekhar Amara, Karthik Reddy Kami Reddy, Yang Yuntao, Yuen San Chan, Danthasinghe Waduge Badrajee Piyarathna, Lacey Elizabeth Dobrolecki, David J H Shih, Zhongcheng Shi, Jun Xu, Shixia Huang, Matthew J Ellis, Andrea B Apolo, Leomar Y Ballester, Jianjun Gao, Donna E Hansel, Yair Lotan, H Courtney Hodges, Seth P Lerner, Chad J Creighton, Arun Sreekumar, Wenjin Jim Zheng, Pavlos Msaouel, Shyam M Kavuri, Nagireddy Putluri
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer. Nature communications 15 (1) (2024)
Alexander D Sherry, Adina H Passy, Zachary Ryan McCaw, Joseph Abi Jaoude, Timothy A Lin, Ramez Kouzy, Avital M Miller, Gabrielle S Kupferman, Esther J Beck, Pavlos Msaouel, Ethan Bernard Ludmir
Increasing Power in Phase III Oncology Trials With Multivariable Regression: An Empirical Assessment of 535 Primary End Point Analyses. JCO clinical cancer informatics 8 (2024)
Alexander D Sherry, Pavlos Msaouel, Ramez Kouzy, Joseph Abi Jaoude, Timothy A Lin, Cullen M Taniguchi, Clifton David Fuller, Bruce D Minsky, Ethan Bernard Ludmir
Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trials. The oncologist (2024)
Andrew C Johns, Matthew T Campbell, Mamie Gao, Andrew W Hahn, Zita Lim, Emily Wang, Jianjun Gao, Amishi Y Shah, Pavlos Msaouel, Nizar M Tannir
Efficacy, Safety, and Tolerability of Tivozanib in Heavily Pretreated Patients With Advanced Clear Cell Renal Cell Carcinoma. The oncologist 29 (7) (2024)
Pavlos Msaouel, Juhee Lee, Peter F Thall
Risk-benefit trade-offs and precision utilities in phase I-II clinical trials. Clinical trials (London, England) 21 (3) (2023)
Luigi Perelli, Federica Carbone, Li Zhang, Justin K Huang, Courtney N Le, Hania Khan, Francesca Citron, Edoardo Del Poggetto, Tony Gutschner, Hideo Tomihara, Melinda Soeung, Rosalba Minelli, Sanjana Srinivasan, Michael Peoples, Truong Nguyen Anh Lam, Sebastian Lundgren, Ruohan Xia, Cihui Zhu, Alaa M T Mohamed, Jianhua Zhang, Kanishka Sircar, Alessandro Sgambato, Jianjun Gao, Eric Jonasch, Giulio F Draetta, P Andrew Futreal, Ziad Bakouny, Eliezer Van Allen, Toni K Choueiri, Sabina Signoretti, Pavlos Msaouel, Kevin Litchfield, Samra Turajlic, Linghua Wang, Ying-Bei Chen, Renzo G DiNatale, A Ari Hakimi, Virginia Giuliani, Timothy P Heffernan, Andrea Viale, Christopher A Bristow, Nizar M Tannir, Alessandro Carugo, Giannicola Genovese
Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer. Nature cancer (2023)
Bujamin H Vokshi, Guillaume Davidson, Nassim Tawanaie Pour Sedehi, Alexandra Helleux, Marc Rippinger, Alexandre R Haller, Justine Gantzer, Jonathan Thouvenin, Philippe Baltzinger, Rachida Bouarich, Valeria Manriquez, Sakina Zaidi, Priya Rao, Pavlos Msaouel, Xiaoping Su, Hervé Lang, Thibault Tricard, Véronique Lindner, Didier Surdez, Jean-Emmanuel Kurtz, Franck Bourdeaut, Nizar M Tannir, Irwin Davidson, Gabriel G Malouf
SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance. Nature communications 14 (1) (2023)
Jose Antonio Karam, Pavlos Msaouel, Cara L Haymaker, Surena F Matin, Matthew T Campbell, Amado J Zurita, Amishi Yogesh Shah, Ignacio I Wistuba, Enrica Marmonti, Dzifa Y Duose, Edwin Roger Parra Cuentes, Luisa Maren Solis Soto, Caddie Laberiano Fernández, Marisa Lozano, Alice Abraham, Max Hallin, Curtis D Chin, Peter Olson, Hirak Der-Torossian, Xiaohong Yan, Nizar M Tannir, Christopher G Wood
Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma. Nature communications 14 (1) (2023)
Jose Antonio Karam, Pavlos Msaouel, Cara L Haymaker, Surena F Matin, Matthew T Campbell, Amado J Zurita, Amishi Yogesh Shah, Ignacio I Wistuba, Enrica Marmonti, Dzifa Y Duose, Edwin Roger Parra Cuentes, Luisa Maren Solis Soto, Caddie Laberiano Fernández, Marisa Lozano, Alice Abraham, Max Hallin, Curtis D Chin, Peter Olson, Hirak Der-Torossian, Xiaohong Yan, Nizar M Tannir, Christopher G Wood
Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma. Nature communications 14 (1) (2023)
Melinda Soeung, Luigi Perelli, Ziheng Chen, Eleonora Dondossola, I-Lin Ho, Federica Carbone, Li Zhang, Hania Khan, Courtney N Le, Cihui Zhu, Michael D Peoples, Ningping Feng, Shan Jiang, Niki Millward Zacharias, Rosalba Minelli, Daniel D Shapiro, Angela K Deem, Sisi Gao, Emily H Cheng, Donatella Lucchetti, Cheryl L Walker, Alessandro Carugo, Virginia Giuliani, Timothy P Heffernan, Andrea Viale, Nizar M Tannir, Giulio F Draetta, Pavlos Msaouel, Giannicola Genovese
SMARCB1 regulates the hypoxic stress response in sickle cell trait. Proceedings of the National Academy of Sciences of the United States of America 120 (21) (2023)
J Bryan Iorgulescu, Leah K Shaw, Asif Rashid, Priya Rao, Sreedhar Mandayam, Keyur P Patel, Kathleen M Schmeler, Richard K Yang, Pavlos Msaouel
Müllerian-Type Clear Cell Carcinoma of Donor Origin in a Male Patient with a Kidney Transplant: Ascertained by Molecular Testing. Current oncology (Toronto, Ont.) 30 (10) (2023)
Melinda Soeung, Luigi Perelli, Ziheng Chen, Eleonora Dondossola, I-Lin Ho, Federica Carbone, Li Zhang, Hania Khan, Courtney N Le, Cihui Zhu, Michael D Peoples, Ningping Feng, Shan Jiang, Niki Millward Zacharias, Rosalba Minelli, Daniel D Shapiro, Angela K Deem, Sisi Gao, Emily H Cheng, Donatella Lucchetti, Cheryl L Walker, Alessandro Carugo, Virginia Giuliani, Timothy P Heffernan, Andrea Viale, Nizar M Tannir, Giulio F Draetta, Pavlos Msaouel, Giannicola Genovese
SMARCB1 regulates the hypoxic stress response in sickle cell trait. Proceedings of the National Academy of Sciences of the United States of America 120 (21) (2023)
Pavlos Msaouel, Juhee Lee, Peter F Thall
Risk-benefit trade-offs and precision utilities in phase I-II clinical trials. Clinical trials (London, England) 21 (3) (2023)
Sanila Sarkar, Whitney Throckmorton, Racheal Bingham, Pavlos Msaouel, Giannicola Genovese, John Slopis, Priya Rao, Zsila Sadighi, Cynthia E Herzog
Renal Cell Carcinoma Unclassified with Medullary Phenotype in a Patient with Neurofibromatosis Type 2. Current oncology (Toronto, Ont.) 30 (3) (2023)
Sanila Sarkar, Whitney Throckmorton, Racheal Bingham, Pavlos Msaouel, Giannicola Genovese, John Slopis, Priya Rao, Zsila Sadighi, Cynthia E Herzog
Renal Cell Carcinoma Unclassified with Medullary Phenotype in a Patient with Neurofibromatosis Type 2. Current oncology (Toronto, Ont.) 30 (3) (2023)
Sanila Sarkar, Whitney Throckmorton, Racheal Bingham, Pavlos Msaouel, Giannicola Genovese, John Slopis, Priya Rao, Zsila Sadighi, Cynthia E Herzog
Renal Cell Carcinoma Unclassified with Medullary Phenotype in a Patient with Neurofibromatosis Type 2. Current oncology (Toronto, Ont.) 30 (3) (2023)
Melinda Soeung, Luigi Perelli, Ziheng Chen, Eleonora Dondossola, I-Lin Ho, Federica Carbone, Li Zhang, Hania Khan, Courtney N Le, Cihui Zhu, Michael D Peoples, Ningping Feng, Shan Jiang, Niki Millward Zacharias, Rosalba Minelli, Daniel D Shapiro, Angela K Deem, Sisi Gao, Emily H Cheng, Donatella Lucchetti, Cheryl L Walker, Alessandro Carugo, Virginia Giuliani, Timothy P Heffernan, Andrea Viale, Nizar M Tannir, Giulio F Draetta, Pavlos Msaouel, Giannicola Genovese
SMARCB1 regulates the hypoxic stress response in sickle cell trait. Proceedings of the National Academy of Sciences of the United States of America 120 (21) (2023)
Peter F Thall, Yong Zang, Andrew Genius Chapple, Ying Yuan, Ruitao Lin, David Marin, Pavlos Msaouel
Novel clinical trial designs with dose optimization to improve long-term outcomes. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Daniel D Shapiro, Niki Zacharias Millward, Durga N Tripathi, Menuka Karki, Jean-Philippe Bertocchio, Melinda Soeung, Rong He, Mary E Westerman, Jianjun Gao, Priya Rao, Truong N A Lam, Eric Jonasch, Luigi Perelli, Emily H Cheng, Alessandro Carugo, Timothy P Heffernan, Cheryl L Walker, Giannicola Genovese, Nizar M Tannir, Jose A Karam, Pavlos Msaouel
Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapy. Clinical and translational medicine 13 (5) (2023)
Andrew W Hahn, Neha Venkatesh, Pavlos Msaouel, Jennifer L McQuade
The Influence of Obesity on Outcomes with Immune Checkpoint Blockade: Clinical Evidence and Potential Biological Mechanisms. Cells 12 (21) (2023)
Pavlos Msaouel, Juhee Lee, Peter F Thall
Risk-benefit trade-offs and precision utilities in phase I-II clinical trials. Clinical trials (London, England) 21 (3) (2023)
Pavlos Msaouel, Juhee Lee, Peter F Thall
Risk-benefit trade-offs and precision utilities in phase I-II clinical trials. Clinical trials (London, England) 21 (3) (2023)
Omar Alhalabi, Jonathan Thouvenin, Sylvie Négrier, Yann-Alexandre Vano, Luca Campedel, Elshad Hasanov, Ziad Bakouny, Andrew W Hahn, Mehmet Asim Bilen, Pavlos Msaouel, Toni K Choueiri, Srinivas R Viswanathan, Kanishka Sircar, Laurence Albiges, Gabriel G Malouf, Nizar M Tannir
Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas. The oncologist (2023)
Pavlos Msaouel, Juhee Lee, Peter F Thall
Interpreting Randomized Controlled Trials. Cancers 15 (19) (2023)
Pavlos Msaouel, Juhee Lee, Peter F Thall
Risk-benefit trade-offs and precision utilities in phase I-II clinical trials. Clinical trials (London, England) (2023)
Pavlos Msaouel, Juhee Lee, Peter F Thall
Risk-benefit trade-offs and precision utilities in phase I-II clinical trials. Clinical trials (London, England) (2023)
Andrew W Hahn, Devaki Shilpa Surasi, Paul V Viscuse, Tharakeswara K Bathala, Andrew J Wiele, Matthew T Campbell, Amado J Zurita, Amishi Y Shah, Eric Jonasch, Jianjun Gao, Sangeeta Goswami, Omar Alhalabi, Priya Rao, Kanishka Sircar, Nizar M Tannir, Pavlos Msaouel
Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy. The oncologist (2023)
Pavlos Msaouel, Juhee Lee, Peter F Thall
Risk-benefit trade-offs and precision utilities in phase I-II clinical trials. Clinical trials (London, England) (2023)
Chijioke Nze, Pavlos Msaouel, Mohamed H Derbala, Bettzy Stephen, Abdulrahman Abonofal, Funda Meric-Bernstam, Nizar M Tannir, Aung Naing
A Phase II Clinical Trial of Pembrolizumab Efficacy and Safety in Advanced Renal Medullary Carcinoma. Cancers 15 (15) (2023)
Daniele Robesti, Luigi Nocera, Federico Belladelli, Julianne G Schultz, Giuseppe Fallara, Laura Marandino, Daniele Raggi, Francesco Montorsi, Pavlos Msaouel, Andrea Necchi, Alberto Martini
The immune-related adverse events paradox in locally advanced or metastatic urothelial cancer after atezolizumab immunotherapy: Analysis of individual patient data from IMvigor210 and IMvigor211 Trials. BJU international (2023)
Jose Antonio Karam, Pavlos Msaouel, Cara L Haymaker, Surena F Matin, Matthew T Campbell, Amado J Zurita, Amishi Yogesh Shah, Ignacio I Wistuba, Enrica Marmonti, Dzifa Y Duose, Edwin Roger Parra Cuentes, Luisa Maren Solis Soto, Caddie Laberiano Fernández, Marisa Lozano, Alice Abraham, Max Hallin, Curtis D Chin, Peter Olson, Hirak Der-Torossian, Xiaohong Yan, Nizar M Tannir, Christopher G Wood
Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma. Nature communications 14 (1) (2023)
Pavlos Msaouel
The Big Data Paradox in Clinical Practice. Cancer investigation 40 (7) (2022)
Pavlos Msaouel, Juhee Lee, Jose A Karam, Peter F Thall
A Causal Framework for Making Individualized Treatment Decisions in Oncology. Cancers 14 (16) (2022)
Pavlos Msaouel
Less is More? First Impressions From COSMIC-313. Cancer investigation (2022)
Pavlos Msaouel, Sangeeta Goswami, Peter F Thall, Xuemei Wang, Ying Yuan, Eric Jonasch, Jianjun Gao, Matthew T Campbell, Amishi Yogesh Shah, Paul Gettys Corn, Alda L Tam, Kamran Ahrar, Priya Rao, Kanishka Sircar, Lorenzo Cohen, Sreyashi Basu, Fei Duan, Sonali Jindal, Yuwei Zhang, Hong Chen, Shalini Singh Yadav, Ronald Shazer, Hirak Der-Torossian, James P Allison, Padmanee Sharma, Nizar M Tannir
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy. Science translational medicine 14 (641) (2022)
Gary H Lyman, Pavlos Msaouel, Nicole M Kuderer
Risk Model Development and Validation in Clinical Oncology: Lessons Learned. Cancer investigation (2022)
Juhee Lee, Peter F Thall, Pavlos Msaouel
Bayesian treatment screening and selection using subgroup-specific utilities of response and toxicity. Biometrics (2022)
Mary E Westerman, Kelly K Bree, Pavlos Msaouel, Janet Baack Kukreja, Cheryl Mantaring, Innocent Rukundo, Martha Garcia Gonzalez, Justin R Gregg, Kelly N Casteel, Surena F Matin
Apixaban vs Enoxaparin for Post-Surgical Extended-Duration Venous Thromboembolic Event Prophylaxis: A Prospective Quality Improvement Study. The Journal of urology 208 (4) (2022)
Alberto Carmona-Bayonas, Paula Jiménez-Fonseca, Javier Gallego, Pavlos Msaouel
Causal Considerations Can Inform the Interpretation of Surprising Associations in Medical Registries. Cancer investigation (2021)
Vicente Valentí, Paula Jiménez-Fonseca, Pavlos Msaouel, Ramón Salazar, Alberto Carmona-Bayonas
Fooled by Randomness. The Misleading Effect of Treatment Crossover in Randomized Trials of Therapies with Marginal Treatment Benefit. Cancer investigation 40 (2) (2021)
Pavlos Msaouel
Impervious to Randomness: Confounding and Selection Biases in Randomized Clinical Trials. Cancer investigation 39 (10) (2021)
Andrew J Wiele, Tharakeswara K Bathala, Andrew W Hahn, Lianchun Xiao, Munevver Duran, Jeremy A Ross, Eric Jonasch, Amishi Yogesh Shah, Matthew T Campbell, Pavlos Msaouel, Nizar M Tannir
Lenvatinib with or Without Everolimus in Patients with Metastatic Renal Cell Carcinoma After Immune Checkpoint Inhibitors and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapies. The oncologist 26 (6) (2021)
Brian Sandeep De, Aradhana M Venkatesan, Pavlos Msaouel, Amol J Ghia, Jing Li, Debra N Yeboa, Quynh-Nhu Nguyen, Andrew J Bishop, Eric Jonasch, Amishi Y Shah, Matthew T Campbell, Jennifer Wang, Amado J Zurita-Saavedra, Jose A Karam, Christopher G Wood, Surena F Matin, Nizar M Tannir, Chad Tang
Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation. BJU international (2021)
Menuka Karki, Rahul K Jangid, Ramakrishnan Anish, Riyad N H Seervai, Jean-Philippe Bertocchio, Takashi Hotta, Pavlos Msaouel, Sung Yun Jung, Sandra L Grimm, Cristian Coarfa, Bernard E Weissman, Ryoma Ohi, Kristen J Verhey, H Courtney Hodges, Warren W Burggren, Ruhee Dere, In Young Park, B V Venkataram Prasad, W Kimryn Rathmell, Cheryl Lyn Walker, Durga Nand Tripathi
A cytoskeletal function for PBRM1 reading methylated microtubules. Science advances 7 (14) (2021)
Juhee Lee, Peter F Thall, Pavlos Msaouel
Precision Bayesian phase I-II dose-finding based on utilities tailored to prognostic subgroups. Statistics in medicine 40 (24) (2021)
Stepan M Esagian, Ali Raza Khaki, Leonidas N Diamantopoulos, Lucia Carril-Ajuria, Daniel Castellano, Ivan De Kouchkovsky, Joseph J Park, Ajjai Alva, Mehmet A Bilen, Tyler F Stewart, Rana R McKay, Victor S Santos, Neeraj Agarwal, Jayanshu Jain, Yousef Zakharia, Rafael Morales-Barrera, Michael E Devitt, Ariel Nelson, Christopher J Hoimes, Evan Shreck, Benjamin A Gartrell, Alex Sankin, Abhishek Tripathi, Roubini Zakopoulou, Aristotelis Bamias, Alejo Rodriguez-Vida, Alexandra Drakaki, Sandy Liu, Vivek Kumar, Mark P Lythgoe, David J Pinato, Jure Murgic, Ana Fröbe, Monika Joshi, Pedro Isaacsson Velho, Noah Hahn, Lucia Alonso Buznego, Ignacio Duran, Marcus Moses, Pedro Barata, Matthew D Galsky, Guru Sonpavde, Evan Y Yu, Pavlos Msaouel, Vadim S Koshkin, Petros Grivas
Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes. BJU international 128 (2) (2021)
Daniel D Shapiro, Melinda Soeung, Luigi Perelli, Eleonora Dondossola, Devaki Shilpa Surasi, Durga N Tripathi, Jean-Philippe Bertocchio, Federica Carbone, Michael W Starbuck, Michael L Van Alstine, Priya Rao, Matthew H G Katz, Nathan H Parker, Amishi Yogesh Shah, Alessandro Carugo, Timothy P Heffernan, Keri L Schadler, Christopher Logothetis, Cheryl L Walker, Christopher G Wood, Jose A Karam, Giulio F Draetta, Nizar M Tannir, Giannicola Genovese, Pavlos Msaouel
Association of High-Intensity Exercise with Renal Medullary Carcinoma in Individuals with Sickle Cell Trait: Clinical Observations and Experimental Animal Studies. Cancers 13 (23) (2021)
Pavlos Msaouel, Giannicola Genovese, Jianjun Gao, Suvajit Sen, Nizar M Tannir
TAM kinase inhibition and immune checkpoint blockade- a winning combination in cancer treatment? Expert opinion on therapeutic targets 25 (2) (2020)
Pavlos Msaouel, Cheryl L Walker, Giannicola Genovese, Nizar M Tannir
Molecular hallmarks of renal medullary carcinoma: more to c-MYC than meets the eye. Molecular & cellular oncology 7 (5) (2020)
Omar Alhalabi, Andrew W Hahn, Pavlos Msaouel, Alexander Y Andreev-Drakhlin, Funda Meric-Bernstam, Aung Naing, Sarina Piha-Paul, Filip Janku, Shubham Pant, Timothy Anthony Yap, David S Hong, Siqing Fu, Daniel Karp, Matthew T Campbell, Hung Le, Amishi Y Shah, Nizar M Tannir, Arlene O Siefker-Radtke, Jianjun Gao, Jason Roszik, Vivek Subbiah
Molecular Profiling of Metastatic Bladder Cancer Early-Phase Clinical Trial Participants Predicts Patient Outcomes. Molecular cancer research : MCR 19 (3) (2020)
Cristiane Decat Bergerot, Dena Battle, Errol J Philip, Paulo Gustavo Bergerot, Pavlos Msaouel, Allan 'Ben' Smith, Adeola Esther Bamgboje, Brian Shuch, Ithaar H Derweesh, Eric Jonasch, Adam P Stern, Sumanta Kumar Pal, Michael D Staehler
Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma. JCO oncology practice 16 (11) (2020)
Pavlos Msaouel, Richard J Gralla, Randy A Jones, Patricia J Hollen
Key issues affecting quality of life and patient-reported outcomes in prostate cancer: an analysis conducted in 2128 patients with initial psychometric assessment of the prostate cancer symptom scale (PCSS). BMJ supportive & palliative care 7 (3) (2017)